Development of an optimal dose regimen of esomeprazole for GERD with minimal influence of CYP2C19 polymorphism
碩士 === 臺北醫學大學 === 藥學研究所 === 95 === Background: Proton pump inhibitors have been the most effective treatment for gastroesophageal reflux disease. However, there is approximately 10-20% of patients have failed to this medication. This inter-indiviual variety may be due to CYP2C19 polymorphism. Purpo...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2007
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/57002232876051605009 |